Coronary artery perforation during chronic total occlusion percutaneous coronary intervention: epidemiology,

Lorenzo Azzalini1, Enrico Poletti, Mohamed Ayoub

  • 1Interventional Cardiology Division, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy.

Insights

Coronary artery perforation occurs in 5.5% of chronic total occlusion (CTO) percutaneous coronary interventions (PCI), often needing intervention and increasing mortality risk. CTO vessel perforations carry the highest risk of complications and death.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology

Background:

  • Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is a complex procedure.
  • Coronary artery perforation is a rare but serious complication of PCI.

Purpose of the Study:

  • To investigate the epidemiology, mechanisms, management, and outcomes of coronary artery perforation during CTO PCI.
  • To identify risk factors and consequences of coronary perforation in CTO PCI patients.

Main Methods:

  • Retrospective analysis of 1,811 patients undergoing CTO PCI across five centers (2011-2018).
  • Detailed review of perforation incidence, types (Ellis classification), causative approaches (antegrade vs. retrograde), interventions, and management strategies.
  • Statistical analysis to determine factors associated with perforation and outcomes.

Main Results:

  • Coronary perforation occurred in 5.5% of CTO PCI cases (n=99).
  • Perforation was associated with older age, higher J-CTO scores, antegrade dissection/re-entry, retrograde approach, and lower success rates.
  • Management included observation (47%), covered stents (25%), balloon occlusion (9%), and embolization (9%). Tamponade occurred in 20%, with in-hospital mortality of 5.1% in perforated cases versus 0.3% in non-perforated cases.
  • Ellis type III perforations, particularly at the CTO site, were linked to tamponade and mortality.

Conclusions:

  • Coronary perforation is a significant complication of CTO PCI, requiring intervention in over half of cases.
  • Perforation is associated with increased rates of tamponade and mortality, especially when related to the CTO vessel.
  • Risk factors include older age, longer occlusions, and specific PCI techniques like retrograde approach and dissection/re-entry.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
922
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
391
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
290
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
223
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
345
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
609